LEIDEN, The Netherlands–(BUSINESS WIRE)–#COVID19–GenScript Biotech Europe BV announced that it has obtained CE marking for its SARS-CoV-2 diagnostic products to be sold as an in vitro diagnostic (“IVD ...
LEIDEN, Netherlands & BILBAO, Spain--(BUSINESS WIRE)--GenScript Biotech (Netherlands) BV, a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading ...
New Delhi: GenScript Biotech Corporation, a leading global biotechnology company today announced a strategic sales distribution agreement, appointing Premas Life Sciences (PLS) as the exclusive ...
GenScript USA Inc. – a subsidiary of GenScript Biotech Corp. headquartered in Piscataway – announced May 26 it reached an agreement with Euroimmun US Inc. – a Euroimmun subsidiary based in Mountain ...
GenScript's latest at-home rapid test is designed to help individuals make better health decisions regarding SARS-CoV-2 exposure; it detects neutralizing antibodies in patients who have either been ...
GenScript Biotech Europe BV announced that it has obtained CE marking for its SARS-CoV-2 diagnostic products to be sold as an in vitro diagnostic ("IVD"). Among these products is the novel cPass TM ...
Exclusive agreement for region brings GenScript's innovative cPass™ kit to Spain, Portugal and Andorra GenScript Biotech (Netherlands) BV, a subsidiary of GenScript Biotech Corporation ("GenScript", ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results